These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Safdar N; Crnich CJ; Maki DG Respir Care; 2005 Jun; 50(6):725-39; discussion 739-41. PubMed ID: 15913465 [TBL] [Abstract][Full Text] [Related]
8. The microbiology of ventilator-associated pneumonia. Park DR Respir Care; 2005 Jun; 50(6):742-63; discussion 763-5. PubMed ID: 15913466 [TBL] [Abstract][Full Text] [Related]
9. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia. Bradley JS Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664 [TBL] [Abstract][Full Text] [Related]
10. Ventilator-associated bacterial pneumonia: challenges in diagnosis, treatment, and prevention. Craven DE; Steger KA New Horiz; 1998 May; 6(2 Suppl):S30-45. PubMed ID: 9654310 [TBL] [Abstract][Full Text] [Related]
11. What is healthcare-associated pneumonia, and how should it be treated? Craven DE Curr Opin Infect Dis; 2006 Apr; 19(2):153-60. PubMed ID: 16514340 [TBL] [Abstract][Full Text] [Related]
13. When can empiric therapy for intensive care unit-acquired pneumonia be withheld or withdrawn? Koeman M; Bonten MJ Semin Respir Infect; 2003 Jun; 18(2):122-8. PubMed ID: 12840793 [TBL] [Abstract][Full Text] [Related]
14. A practical application of practice-based learning: development of an algorithm for empiric antibiotic coverage in ventilator-associated pneumonia. Miller PR; Partrick MS; Hoth JJ; Meredith JW; Chang MC J Trauma; 2006 Apr; 60(4):725-9; discussion 729-31. PubMed ID: 16612290 [TBL] [Abstract][Full Text] [Related]
15. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721 [TBL] [Abstract][Full Text] [Related]
16. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413 [TBL] [Abstract][Full Text] [Related]
17. Role of mechanical ventilation & development of multidrug resistant organisms in hospital acquired pneumonia. Mukhopadhyay C; Bhargava A; Ayyagari A Indian J Med Res; 2003 Dec; 118():229-35. PubMed ID: 14870795 [TBL] [Abstract][Full Text] [Related]
19. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution]. Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394 [TBL] [Abstract][Full Text] [Related]
20. Nosocomial pneumonia: state of the science. Flanders SA; Collard HR; Saint S Am J Infect Control; 2006 Mar; 34(2):84-93. PubMed ID: 16490612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]